Eco Bright Future, Inc.'s Director, Tomax Strgar, Provides a Letter to Shareholders
08 févr. 2024 09h45 HE
|
Eco Bright Future, Inc.
Eco Bright Future, Inc.'s Director, Tomax Strgar, Provides a Letter to Shareholders
8B Education Investments launches $111,600,000 initiative to Finance African student education at The Clinton Global Initiative
20 sept. 2022 10h49 HE
|
8B Finance
New York, NY, Sept. 20, 2022 (GLOBE NEWSWIRE) -- 8B Education Investments partners with Nelnet Bank in the first ever lending program by a US bank to African students enrolled in American...
Fattah Neuroscience Global Advisors Develops International Partnership to Build African Neuroscience
24 janv. 2022 22h24 HE
|
Fattah Neuroscience Global Advisors
Philadelphia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Recently, Fattah Neuroscience Global Advisors LLC (FNGA), a consulting firm founded by former U.S. Congressman Chaka Fattah, Sr., committed to...
Resverlogix Enters into a Cooperation Agreement with the Supreme Council of the Arab-African Economy to Support the Development of Apabetalone for COVID-19 Patients
03 nov. 2021 08h00 HE
|
Resverlogix Corp
CALGARY, Alberta, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the Company”) (TSX: RVX), a world leader in epigenetics or gene regulation, is pleased to announce today that...
Hammer Expands its SMS and Over-the-Top Services
16 juil. 2019 11h43 HE
|
Hammer Fiber Optics Holdings Corp d/b/a Hammer Communications
PISCATAWAY, N.J., July 16, 2019 (GLOBE NEWSWIRE) -- Hammer Fiber Optics Holdings Corp’s (OTCQB: HMMR) announced today that it has expanded its Over-the-Top services. The 1P-SMSC, offered by Hammer’s...
CORRECTING and REPLACING: Immune Therapeutics, Inc.
22 mai 2017 09h24 HE
|
Immune Therapeutics, Inc.
In a release issued under the same headline earlier today by Immune Therapeutics, Inc. (OTCQB:IMUN), the headline has been corrected to read "Immune Therapeutics Announces NAFDAC Approval...
Immune Therapeutics Announces NAFDAC Approval of Lodonal™ for the Treatment of HIV in Nigeria
22 mai 2017 08h42 HE
|
Immune Therapeutics, Inc.
Highlights: National Agency for Food and Drug Administration and Control (“NAFDAC”) approval paves way for Immune Therapeutics’ first significant revenue channel Immune Therapeutics’ goal to capture...
Immune Therapeutics, Inc. Files Lodonal New Drug Application in Kenya
25 avr. 2017 11h37 HE
|
Immune Therapeutics, Inc.
ORLANDO, Fla., April 25, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using LodonalTM...
Immune Therapeutics, Inc. Strengthens Balance Sheet With Debt Settlement
12 avr. 2017 13h36 HE
|
Immune Therapeutics, Inc.
ORLANDO, Fla., April 12, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using LodonalTM,...
Immune Therapeutics Clears Critical Regulatory Hurdle for Lodonal in Kenya
17 mars 2017 09h07 HE
|
Immune Therapeutics, Inc.
ORLANDO, Fla., March 17, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using Lodonal™,...